Picture of Aktis Oncology logo

AKTS — Aktis Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSucker Stock

Brief: Akoustis Reports Fiscal First Quarter 2022 Results

Nov 1 (Reuters) - Akoustis Technologies Inc  AKTS.O :
    * AKOUSTIS REPORTS FISCAL FIRST QUARTER 2022 RESULTS
    * Q1 REVENUE ROSE 300 PERCENT TO $1.9 MILLION
    * QTRLY NON-GAAP NET LOSS PER SHARE $0.21
    * QTRLY LOSS PER SHARE $0.25

Source text for Eikon:  ID:nGNXfq7q9 
Further company coverage:  AKTS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aktis Oncology

See all news